Bain Capital has completed the sale of $58.9 million worth of stock in Heartflow, a company listed on the NASDAQ under the ticker HTFL. This transaction marks a significant divestment by the investment firm, although further details regarding the timing and implications of the sale have not been disclosed. Heartflow specializes in providing advanced cardiovascular diagnostic solutions. The sale reflects Bain Capital's ongoing strategy to manage its investment portfolio.
Related Articles
Don't miss out on breaking stories and in-depth articles.